Avoro Capital Advisors’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-324,750
| Closed | -$16.5M | – | 50 |
|
|
2020
Q2 | $16.5M | Sell |
324,750
-875,250
| -73% | -$44.4M | 0.33% | 38 |
|
|
2020
Q1 | $53.5M | Buy |
+1,200,000
| New | +$53.5M | 1.81% | 18 |
|
|
2019
Q4 | – | Sell |
-684,000
| Closed | -$23.1M | – | 33 |
|
|
2019
Q3 | $23.1M | Hold |
684,000
| – | – | 0.97% | 23 |
|
|
2019
Q2 | $30.8M | Buy |
+684,000
| New | +$30.8M | 1.06% | 22 |
|
|
2019
Q1 | – | Sell |
-380,000
| Closed | -$13M | – | 33 |
|
|
2018
Q4 | $13M | Sell |
380,000
-304,000
| -44% | -$10.4M | 0.78% | 23 |
|
|
2018
Q3 | $32.1M | Sell |
684,000
-1,610,877
| -70% | -$75.7M | 1.48% | 18 |
|
|
2018
Q2 | $77.4M | Buy |
+2,294,877
| New | +$77.4M | 2.98% | 11 |
|
|
2017
Q3 | – | Sell |
-120,000
| Closed | -$2.2M | – | 43 |
|
|
2017
Q2 | $2.2M | Buy |
+120,000
| New | +$2.2M | 0.28% | 34 |
|